ArticleNature communications2026

Aberrant laminin signaling drives melanocyte dedifferentiation and unveils a tractable therapeutic target in vitiligo.

Fei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.